| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |